Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Pharmaxis Ltd ( (AU:SNT) ) just unveiled an announcement.
Syntara Limited announced a general meeting to be held virtually on February 17, 2025, to seek shareholder approval for the second tranche of a two-tranche placement, which aims to raise a total of $15 million. This includes a significant investment by a fund associated with a company director and involves issuing a total of 250 million shares. The meeting also seeks approval to grant options as compensation for corporate advisory services. This move is part of Syntara’s efforts to strengthen its financial position and expand its share issuance capacity under ASX rules, potentially impacting its growth and market positioning.
More about Pharmaxis Ltd
YTD Price Performance: -8.75%
Average Trading Volume: 5,199,992
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$113.7M
See more data about SNT stock on TipRanks’ Stock Analysis page.
